Correlation Between Bayer AG and ASTELLAS PHARMA

Can any of the company-specific risk be diversified away by investing in both Bayer AG and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bayer AG and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bayer AG NA and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on Bayer AG and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bayer AG with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bayer AG and ASTELLAS PHARMA.

Diversification Opportunities for Bayer AG and ASTELLAS PHARMA

0.82

Correlation Coefficient

Bayer AG  ASTELLAS PHARMA

Very poor diversification

The 3 months correlation between Bayer and ASTELLAS is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Bayer AG NA and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and Bayer AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bayer AG NA are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of Bayer AG i.e., Bayer AG and ASTELLAS PHARMA go up and down completely randomly.

Pair Corralation between Bayer AG and ASTELLAS PHARMA

Assuming the 90 days trading horizon Bayer AG NA is expected to under-perform the ASTELLAS PHARMA. In addition to that, Bayer AG is 1.6 times more volatile than ASTELLAS PHARMA UNSPADR. It trades about -0.16 of its total potential returns per unit of risk. ASTELLAS PHARMA UNSPADR is currently generating about -0.07 per unit of volatility. If you would invest  1,034  in ASTELLAS PHARMA UNSPADR on September 13, 2024 and sell it today you would lose (79.00) from holding ASTELLAS PHARMA UNSPADR or give up 7.64% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Bayer AG NA  vs.  ASTELLAS PHARMA UNSPADR

Bayer AG NA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bayer AG NA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

ASTELLAS PHARMA UNSPADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Bayer AG and ASTELLAS PHARMA

The main advantage of trading using opposite Bayer AG and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bayer AG position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.

The idea behind Bayer AG NA and ASTELLAS PHARMA UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.